Almost everything about the new blood-thinning drug, dabigatran (Pradaxa) is novel. In February, I wrote about the drug’s unusually short (thirty-day) expiration time. This week, the FDA has released a new communication concerning dabigatran. It included practical safety tips for patients, pharmacists and doctors, and is nicely summarized by Larry Husten, on Cardiobrief. Here are […]
Tag: Pradaxa
There was important news concerning the short shelf-life of the novel new blood-thinner, dabigatran (Pradaxa) reported today. Once dispensed, most medicines expire after a year. Dabigatran, however, is far from the usual pill. It’s packaged in pellet form within a capsule. These pellets are highly susceptible to water and humidity. So when dispensed in a […]
The experiment took thirty-three minutes and forty-one seconds.  That’s about the time it takes to see a new heart-rhythm patient or implant a defibrillator. I was just curious. I wanted to dip my toes into the icy waters which so many primary care doctors have already acclimated to. A denial? Are they kidding, that medicine […]